

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.07766944 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.07766944 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.75525693 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.75525693 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.34311015 |
| 6 | glycosphingolipid catabolic process (GO:0046479) | 5.95081904 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.78366304 |
| 8 | melanin biosynthetic process (GO:0042438) | 5.73459129 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.70975594 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.70975594 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.70975594 |
| 12 | glycolipid catabolic process (GO:0019377) | 5.61386569 |
| 13 | Golgi transport vesicle coating (GO:0048200) | 5.44700520 |
| 14 | COPI coating of Golgi vesicle (GO:0048205) | 5.44700520 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.43720449 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.39187054 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.31290090 |
| 18 | urea metabolic process (GO:0019627) | 5.22763637 |
| 19 | urea cycle (GO:0000050) | 5.22763637 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.16315880 |
| 21 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.04799344 |
| 22 | ceramide catabolic process (GO:0046514) | 5.04418113 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.94502377 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.93341715 |
| 25 | protein carboxylation (GO:0018214) | 4.93341715 |
| 26 | glyoxylate metabolic process (GO:0046487) | 4.90742191 |
| 27 | tyrosine metabolic process (GO:0006570) | 4.90228576 |
| 28 | melanin metabolic process (GO:0006582) | 4.88451268 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.86315773 |
| 30 | cysteine metabolic process (GO:0006534) | 4.86080884 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 4.82900103 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.81051455 |
| 33 | complement activation, alternative pathway (GO:0006957) | 4.80729043 |
| 34 | regulation of fibrinolysis (GO:0051917) | 4.77393996 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.74891862 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.73400230 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.69607920 |
| 38 | sphingolipid catabolic process (GO:0030149) | 4.68534063 |
| 39 | regulation of protein activation cascade (GO:2000257) | 4.65983075 |
| 40 | membrane lipid catabolic process (GO:0046466) | 4.65873792 |
| 41 | bile acid metabolic process (GO:0008206) | 4.57438869 |
| 42 | phospholipid efflux (GO:0033700) | 4.51808088 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.45883809 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.42922958 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.42922958 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.42922958 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.42359255 |
| 48 | secondary metabolite biosynthetic process (GO:0044550) | 4.38049283 |
| 49 | serine family amino acid catabolic process (GO:0009071) | 4.36389983 |
| 50 | regulation of complement activation (GO:0030449) | 4.35436296 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.20792852 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.20792852 |
| 53 | homocysteine metabolic process (GO:0050667) | 4.14283932 |
| 54 | amine catabolic process (GO:0009310) | 4.13285160 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 4.13285160 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.12625709 |
| 57 | indolalkylamine metabolic process (GO:0006586) | 4.12256753 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.10592486 |
| 59 | aldehyde catabolic process (GO:0046185) | 4.08660478 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.05916124 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.05135834 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.04689107 |
| 63 | cellular glucuronidation (GO:0052695) | 4.01769834 |
| 64 | cholesterol efflux (GO:0033344) | 4.00934269 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 3.99220584 |
| 66 | negative regulation of sterol transport (GO:0032372) | 3.99220584 |
| 67 | bile acid and bile salt transport (GO:0015721) | 3.95317101 |
| 68 | low-density lipoprotein particle remodeling (GO:0034374) | 3.87150104 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 3.86073820 |
| 70 | cofactor catabolic process (GO:0051187) | 3.84822086 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 3.81224159 |
| 72 | NAD biosynthetic process (GO:0009435) | 3.79929871 |
| 73 | lysine catabolic process (GO:0006554) | 3.79778793 |
| 74 | lysine metabolic process (GO:0006553) | 3.79778793 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 3.79610779 |
| 76 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77810479 |
| 77 | * endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.77493440 |
| 78 | oligosaccharide catabolic process (GO:0009313) | 3.75196100 |
| 79 | ethanol oxidation (GO:0006069) | 3.73931613 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71260339 |
| 81 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71260339 |
| 82 | glucuronate metabolic process (GO:0019585) | 3.71161835 |
| 83 | uronic acid metabolic process (GO:0006063) | 3.71161835 |
| 84 | NADH metabolic process (GO:0006734) | 3.69586801 |
| 85 | cellular ketone body metabolic process (GO:0046950) | 3.69585508 |
| 86 | glycine metabolic process (GO:0006544) | 3.66963248 |
| 87 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.65388294 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.64964093 |
| 89 | fibrinolysis (GO:0042730) | 3.63261578 |
| 90 | amino sugar catabolic process (GO:0046348) | 3.62894579 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 3.62410727 |
| 92 | arginine metabolic process (GO:0006525) | 3.61901380 |
| 93 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.59439525 |
| 94 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59439525 |
| 95 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58572446 |
| 96 | serine family amino acid metabolic process (GO:0009069) | 3.54695849 |
| 97 | protein activation cascade (GO:0072376) | 3.54533826 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.52828604 |
| 99 | glutamate metabolic process (GO:0006536) | 3.48998908 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.48617816 |
| 101 | complement activation (GO:0006956) | 3.46658345 |
| 102 | organic acid catabolic process (GO:0016054) | 3.44149574 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.44149574 |
| 104 | protein maturation by protein folding (GO:0022417) | 3.43574512 |
| 105 | ketone body metabolic process (GO:1902224) | 3.43026107 |
| 106 | opsonization (GO:0008228) | 3.42632325 |
| 107 | protein retention in ER lumen (GO:0006621) | 3.41301639 |
| 108 | acute-phase response (GO:0006953) | 3.40203571 |
| 109 | protein-lipid complex assembly (GO:0065005) | 3.38578292 |
| 110 | response to nitrosative stress (GO:0051409) | 3.38233829 |
| 111 | cholesterol homeostasis (GO:0042632) | 3.34923696 |
| 112 | short-chain fatty acid metabolic process (GO:0046459) | 3.33991447 |
| 113 | tricarboxylic acid cycle (GO:0006099) | 3.33002268 |
| 114 | phospholipid homeostasis (GO:0055091) | 3.31908372 |
| 115 | response to thyroid hormone (GO:0097066) | 3.30530302 |
| 116 | cellular response to arsenic-containing substance (GO:0071243) | 3.30151083 |
| 117 | positive regulation of lipid catabolic process (GO:0050996) | 3.28233201 |
| 118 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.28027421 |
| 119 | sterol homeostasis (GO:0055092) | 3.27705548 |
| 120 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.27206528 |
| 121 | serine family amino acid biosynthetic process (GO:0009070) | 3.26990240 |
| 122 | protein-lipid complex subunit organization (GO:0071825) | 3.25959335 |
| 123 | nitric oxide biosynthetic process (GO:0006809) | 3.25436429 |
| 124 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.24058061 |
| 125 | cytolysis (GO:0019835) | 3.22325901 |
| 126 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.22143560 |
| 127 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.22143560 |
| 128 | protein localization to endosome (GO:0036010) | 3.21776113 |
| 129 | mitochondrial fusion (GO:0008053) | 3.14040787 |
| 130 | keratan sulfate catabolic process (GO:0042340) | 3.13491093 |
| 131 | gluconeogenesis (GO:0006094) | 3.07051772 |
| 132 | glycosylceramide metabolic process (GO:0006677) | 3.02571598 |
| 133 | endosome to melanosome transport (GO:0035646) | 3.02230312 |
| 134 | endosome to pigment granule transport (GO:0043485) | 3.02230312 |
| 135 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.99469648 |
| 136 | adhesion of symbiont to host (GO:0044406) | 2.99415322 |
| 137 | adhesion of symbiont to host cell (GO:0044650) | 2.99300420 |
| 138 | virion attachment to host cell (GO:0019062) | 2.99300420 |
| 139 | transferrin transport (GO:0033572) | 2.97861818 |
| 140 | hexose biosynthetic process (GO:0019319) | 2.95961772 |
| 141 | monosaccharide biosynthetic process (GO:0046364) | 2.92256592 |
| 142 | proline biosynthetic process (GO:0006561) | 2.87363047 |
| 143 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.83900989 |
| 144 | fructose metabolic process (GO:0006000) | 2.79802823 |
| 145 | * amyloid precursor protein catabolic process (GO:0042987) | 2.79671629 |
| 146 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.79630276 |
| 147 | sphingosine metabolic process (GO:0006670) | 2.78366120 |
| 148 | galactose catabolic process (GO:0019388) | 2.77604527 |
| 149 | trivalent inorganic cation transport (GO:0072512) | 2.77524480 |
| 150 | ferric iron transport (GO:0015682) | 2.77524480 |
| 151 | glucosamine-containing compound catabolic process (GO:1901072) | 2.75890743 |
| 152 | pigment cell differentiation (GO:0050931) | 2.75883173 |
| 153 | vitamin D metabolic process (GO:0042359) | 2.74722007 |
| 154 | cellular copper ion homeostasis (GO:0006878) | 2.73515712 |
| 155 | barbed-end actin filament capping (GO:0051016) | 2.61916448 |
| 156 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.58307834 |
| 157 | regulation of protein sumoylation (GO:0033233) | 2.56762559 |
| 158 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.55207029 |
| 159 | regulation of cholesterol storage (GO:0010885) | 2.53814506 |
| 160 | zinc ion transmembrane transport (GO:0071577) | 2.51279425 |
| 161 | macroautophagy (GO:0016236) | 2.50679718 |
| 162 | lipopolysaccharide metabolic process (GO:0008653) | 2.48779137 |
| 163 | muscle cell cellular homeostasis (GO:0046716) | 2.48198796 |
| 164 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.48022721 |
| 165 | galactose metabolic process (GO:0006012) | 2.47781771 |
| 166 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.47559156 |
| 167 | skeletal muscle contraction (GO:0003009) | 2.45682005 |
| 168 | glycosphingolipid metabolic process (GO:0006687) | 2.44475425 |
| 169 | nuclear envelope reassembly (GO:0031468) | 2.43362739 |
| 170 | mitotic nuclear envelope reassembly (GO:0007084) | 2.43362739 |
| 171 | COPII vesicle coating (GO:0048208) | 2.43294123 |
| 172 | epithelial cell-cell adhesion (GO:0090136) | 2.41960110 |
| 173 | pigment biosynthetic process (GO:0046148) | 2.41826504 |
| 174 | inner mitochondrial membrane organization (GO:0007007) | 2.40927326 |
| 175 | actin-myosin filament sliding (GO:0033275) | 2.40838844 |
| 176 | muscle filament sliding (GO:0030049) | 2.40838844 |
| 177 | negative regulation of mitochondrion organization (GO:0010823) | 2.39407627 |
| 178 | glycogen catabolic process (GO:0005980) | 2.38990592 |
| 179 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.38386009 |
| 180 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.38187569 |
| 181 | hyaluronan catabolic process (GO:0030214) | 2.36697538 |
| 182 | eosinophil chemotaxis (GO:0048245) | 2.36605563 |
| 183 | pinocytosis (GO:0006907) | 2.35786676 |
| 184 | regulation of early endosome to late endosome transport (GO:2000641) | 2.35560995 |
| 185 | glycoside metabolic process (GO:0016137) | 2.34484152 |
| 186 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.34368687 |
| 187 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.32984907 |
| 188 | regulation of mononuclear cell migration (GO:0071675) | 2.32769298 |
| 189 | vesicle coating (GO:0006901) | 2.31600665 |
| 190 | protein hydroxylation (GO:0018126) | 2.31373868 |
| 191 | regulation of superoxide anion generation (GO:0032928) | 2.30420783 |
| 192 | creatine metabolic process (GO:0006600) | 2.28712428 |
| 193 | pH reduction (GO:0045851) | 2.27259158 |
| 194 | diol metabolic process (GO:0034311) | 2.27173304 |
| 195 | vasodilation (GO:0042311) | 2.26768840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.31565247 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.50552608 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.25342977 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.51809065 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.93177428 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.72145561 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.28733994 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.98707038 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.25052952 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.14997837 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.14191525 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.05579832 |
| 13 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.56283663 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.50374536 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37644195 |
| 16 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.29722935 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.15019416 |
| 18 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.06818696 |
| 19 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2761029 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.98783656 |
| 21 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.96688069 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91381340 |
| 23 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.88515440 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87438848 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85338794 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.82562497 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76930433 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.72390027 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71140520 |
| 30 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.70552227 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69941430 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.69842947 |
| 33 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.69800311 |
| 34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.69535350 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.68012879 |
| 36 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.64734201 |
| 37 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.63853044 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61812932 |
| 39 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.58268392 |
| 40 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.56186324 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53002913 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.46461472 |
| 43 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.45847052 |
| 44 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45623159 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45051072 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44955275 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.44767817 |
| 48 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.44547820 |
| 49 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.43938357 |
| 50 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.43393056 |
| 51 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.42102255 |
| 52 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41429233 |
| 53 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.39928485 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38214346 |
| 55 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.36998618 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36005084 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35478806 |
| 58 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34503038 |
| 59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.33874020 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33336247 |
| 61 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31475604 |
| 62 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.29924982 |
| 63 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29568527 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28865914 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28541549 |
| 66 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.25175669 |
| 67 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23832763 |
| 68 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.22380181 |
| 69 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.20972929 |
| 70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20860350 |
| 71 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20860350 |
| 72 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.20706778 |
| 73 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.20450879 |
| 74 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.18112266 |
| 75 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17917462 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 1.16684872 |
| 77 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15237946 |
| 78 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.15189490 |
| 79 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14920408 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14459548 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13967409 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13896870 |
| 83 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.13479653 |
| 84 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13076994 |
| 85 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.13041151 |
| 86 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13008481 |
| 87 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.12091921 |
| 88 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11353717 |
| 89 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.08217331 |
| 90 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08123912 |
| 91 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.07946497 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06758699 |
| 93 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06755299 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05760420 |
| 95 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05504955 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05435310 |
| 97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05058242 |
| 98 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.04854426 |
| 99 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.03702675 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03274405 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02552331 |
| 102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01823811 |
| 103 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01558985 |
| 104 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99331605 |
| 105 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99030796 |
| 106 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.98843672 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98187279 |
| 108 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97246322 |
| 109 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96310674 |
| 110 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.95967967 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95869742 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95330046 |
| 113 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.93556453 |
| 114 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93318225 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92594500 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92080282 |
| 117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.91097219 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89083326 |
| 119 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.87772878 |
| 120 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.85898982 |
| 121 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.85820245 |
| 122 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.85220964 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84780260 |
| 124 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83626474 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82812691 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80313099 |
| 127 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.80238900 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77303397 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75251792 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74828583 |
| 131 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.74767228 |
| 132 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73836294 |
| 133 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73291323 |
| 134 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.72445487 |
| 135 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.72158348 |
| 136 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71939797 |
| 137 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.71741136 |
| 138 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.71432415 |
| 139 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.69992401 |
| 140 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.69865929 |
| 141 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.68626444 |
| 142 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68070395 |
| 143 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.67958968 |
| 144 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67770062 |
| 145 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67670386 |
| 146 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.66926688 |
| 147 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.66620030 |
| 148 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.65721963 |
| 149 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65083280 |
| 150 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63647728 |
| 151 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.63385430 |
| 152 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62815263 |
| 153 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.62787380 |
| 154 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62280255 |
| 155 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.60437538 |
| 156 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.60335915 |
| 157 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.59951817 |
| 158 | MYB_26560356_Chip-Seq_TH1_Human | 0.58783007 |
| 159 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.58177514 |
| 160 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.56749723 |
| 161 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.56397584 |
| 162 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.55827721 |
| 163 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.55592199 |
| 164 | GATA3_26560356_Chip-Seq_TH2_Human | 0.55055770 |
| 165 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.54800462 |
| 166 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.54523539 |
| 167 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.54484000 |
| 168 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54118631 |
| 169 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54110492 |
| 170 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.53440042 |
| 171 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.53382451 |
| 172 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53106922 |
| 173 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.52816115 |
| 174 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.52290753 |
| 175 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.52218798 |
| 176 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.51821544 |
| 177 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.51429024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.53368587 |
| 2 | MP0005360_urolithiasis | 6.30123736 |
| 3 | MP0005365_abnormal_bile_salt | 5.61285314 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.50649912 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.58707780 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.79572313 |
| 7 | MP0003252_abnormal_bile_duct | 3.37902058 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.20188226 |
| 9 | MP0009840_abnormal_foam_cell | 3.16009908 |
| 10 | MP0004233_abnormal_muscle_weight | 3.13213090 |
| 11 | MP0005257_abnormal_intraocular_pressure | 3.00947367 |
| 12 | MP0005083_abnormal_biliary_tract | 2.77733882 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.67226226 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.64720812 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.61548888 |
| 16 | MP0003195_calcinosis | 2.59559524 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.58378985 |
| 18 | MP0005171_absent_coat_pigmentation | 2.55794038 |
| 19 | MP0005332_abnormal_amino_acid | 2.39384385 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.38551977 |
| 21 | MP0000751_myopathy | 2.29491973 |
| 22 | MP0000749_muscle_degeneration | 2.26220340 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.25043093 |
| 24 | MP0000015_abnormal_ear_pigmentation | 2.17553522 |
| 25 | MP0003136_yellow_coat_color | 2.13618547 |
| 26 | MP0004510_myositis | 2.12290215 |
| 27 | MP0002090_abnormal_vision | 2.06220451 |
| 28 | MP0000609_abnormal_liver_physiology | 2.05370137 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.99157372 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.92733427 |
| 31 | MP0003646_muscle_fatigue | 1.89926366 |
| 32 | MP0003868_abnormal_feces_composition | 1.86267018 |
| 33 | MP0000747_muscle_weakness | 1.80092914 |
| 34 | MP0001764_abnormal_homeostasis | 1.79109824 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.78069489 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.75530182 |
| 37 | MP0001661_extended_life_span | 1.66576306 |
| 38 | MP0005451_abnormal_body_composition | 1.64678377 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.63911683 |
| 40 | MP0003186_abnormal_redox_activity | 1.63640183 |
| 41 | MP0002269_muscular_atrophy | 1.62449240 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.55860142 |
| 43 | MP0005330_cardiomyopathy | 1.55398838 |
| 44 | MP0003724_increased_susceptibility_to | 1.54237668 |
| 45 | MP0009697_abnormal_copulation | 1.52450550 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52230618 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.46819126 |
| 48 | MP0003879_abnormal_hair_cell | 1.41248062 |
| 49 | MP0006054_spinal_hemorrhage | 1.40997616 |
| 50 | MP0000003_abnormal_adipose_tissue | 1.40193378 |
| 51 | MP0005408_hypopigmentation | 1.39254095 |
| 52 | MP0000343_altered_response_to | 1.39194488 |
| 53 | MP0003011_delayed_dark_adaptation | 1.38180843 |
| 54 | MP0003329_amyloid_beta_deposits | 1.37622546 |
| 55 | MP0008469_abnormal_protein_level | 1.35817006 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.33677547 |
| 57 | MP0005379_endocrine/exocrine_gland_phen | 1.33461553 |
| 58 | MP0009764_decreased_sensitivity_to | 1.32905851 |
| 59 | MP0003436_decreased_susceptibility_to | 1.31253134 |
| 60 | MP0001835_abnormal_antigen_presentation | 1.30635376 |
| 61 | MP0005165_increased_susceptibility_to | 1.30607835 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.27774962 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.26596353 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.24274602 |
| 65 | MP0004272_abnormal_basement_membrane | 1.23819902 |
| 66 | MP0004036_abnormal_muscle_relaxation | 1.21639491 |
| 67 | MP0009763_increased_sensitivity_to | 1.18726418 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.17320916 |
| 69 | MP0000358_abnormal_cell_content/ | 1.15910327 |
| 70 | MP0004381_abnormal_hair_follicle | 1.15775271 |
| 71 | MP0006082_CNS_inflammation | 1.15393143 |
| 72 | MP0000598_abnormal_liver_morphology | 1.15002606 |
| 73 | MP0002075_abnormal_coat/hair_pigmentati | 1.14701408 |
| 74 | MP0009785_altered_susceptibility_to | 1.14542607 |
| 75 | MP0003634_abnormal_glial_cell | 1.14509553 |
| 76 | MP0001324_abnormal_eye_pigmentation | 1.12822017 |
| 77 | MP0000604_amyloidosis | 1.11271894 |
| 78 | MP0001542_abnormal_bone_strength | 1.10571886 |
| 79 | MP0000759_abnormal_skeletal_muscle | 1.08809583 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 1.03391612 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 1.02267989 |
| 82 | MP0005025_abnormal_response_to | 1.02169372 |
| 83 | MP0010386_abnormal_urinary_bladder | 1.01713121 |
| 84 | MP0005197_abnormal_uvea_morphology | 1.01593790 |
| 85 | MP0005647_abnormal_sex_gland | 0.99562600 |
| 86 | MP0001186_pigmentation_phenotype | 0.99470838 |
| 87 | MP0008438_abnormal_cutaneous_collagen | 0.98220356 |
| 88 | MP0004087_abnormal_muscle_fiber | 0.97531384 |
| 89 | MP0002419_abnormal_innate_immunity | 0.97094846 |
| 90 | MP0000750_abnormal_muscle_regeneration | 0.96584654 |
| 91 | MP0005075_abnormal_melanosome_morpholog | 0.95381164 |
| 92 | MP0004270_analgesia | 0.95152061 |
| 93 | MP0010030_abnormal_orbit_morphology | 0.94915888 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.94333200 |
| 95 | MP0009642_abnormal_blood_homeostasis | 0.93310555 |
| 96 | MP0002972_abnormal_cardiac_muscle | 0.91426683 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.90975909 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.90333296 |
| 99 | MP0001790_abnormal_immune_system | 0.89422722 |
| 100 | MP0005387_immune_system_phenotype | 0.89422722 |
| 101 | MP0005375_adipose_tissue_phenotype | 0.88016294 |
| 102 | MP0000685_abnormal_immune_system | 0.87447683 |
| 103 | MP0001845_abnormal_inflammatory_respons | 0.86910242 |
| 104 | MP0001800_abnormal_humoral_immune | 0.86485504 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.85453575 |
| 106 | MP0003718_maternal_effect | 0.84201509 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.83615126 |
| 108 | MP0005084_abnormal_gallbladder_morpholo | 0.83444656 |
| 109 | MP0005671_abnormal_response_to | 0.82682541 |
| 110 | MP0003941_abnormal_skin_development | 0.82673938 |
| 111 | MP0005220_abnormal_exocrine_pancreas | 0.81537592 |
| 112 | MP0002132_abnormal_respiratory_system | 0.81096620 |
| 113 | MP0005620_abnormal_muscle_contractility | 0.79413550 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.76897701 |
| 115 | MP0002106_abnormal_muscle_physiology | 0.76885922 |
| 116 | MP0000733_abnormal_muscle_development | 0.76807304 |
| 117 | MP0005334_abnormal_fat_pad | 0.76793201 |
| 118 | MP0004782_abnormal_surfactant_physiolog | 0.76668676 |
| 119 | MP0005000_abnormal_immune_tolerance | 0.76535162 |
| 120 | MP0001853_heart_inflammation | 0.75841866 |
| 121 | MP0004147_increased_porphyrin_level | 0.75476678 |
| 122 | MP0005670_abnormal_white_adipose | 0.75314170 |
| 123 | MP0000920_abnormal_myelination | 0.75158931 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.75014027 |
| 125 | MP0002723_abnormal_immune_serum | 0.74359793 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.73208824 |
| 127 | MP0005535_abnormal_body_temperature | 0.72280156 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.69963652 |
| 129 | MP0002971_abnormal_brown_adipose | 0.68118429 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.66369709 |
| 131 | MP0002148_abnormal_hypersensitivity_rea | 0.64556887 |
| 132 | MP0003303_peritoneal_inflammation | 0.64126237 |
| 133 | MP0002452_abnormal_antigen_presenting | 0.63408982 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.62297749 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.60683303 |
| 136 | MP0002693_abnormal_pancreas_physiology | 0.60307925 |
| 137 | MP0010368_abnormal_lymphatic_system | 0.60136020 |
| 138 | MP0002254_reproductive_system_inflammat | 0.58701698 |
| 139 | MP0003690_abnormal_glial_cell | 0.58236748 |
| 140 | MP0001756_abnormal_urination | 0.57724722 |
| 141 | MP0003123_paternal_imprinting | 0.56926783 |
| 142 | MP0001849_ear_inflammation | 0.56746394 |
| 143 | MP0002229_neurodegeneration | 0.56639607 |
| 144 | MP0002136_abnormal_kidney_physiology | 0.55470145 |
| 145 | MP0009379_abnormal_foot_pigmentation | 0.55308224 |
| 146 | MP0010155_abnormal_intestine_physiology | 0.53542767 |
| 147 | MP0008260_abnormal_autophagy | 0.53009488 |
| 148 | MP0002420_abnormal_adaptive_immunity | 0.52124309 |
| 149 | MP0002095_abnormal_skin_pigmentation | 0.51881530 |
| 150 | MP0001819_abnormal_immune_cell | 0.51609248 |
| 151 | MP0002928_abnormal_bile_duct | 0.51414938 |
| 152 | MP0002166_altered_tumor_susceptibility | 0.50471728 |
| 153 | MP0004947_skin_inflammation | 0.50327942 |
| 154 | MP0005448_abnormal_energy_balance | 0.50175315 |
| 155 | MP0008873_increased_physiological_sensi | 0.49650439 |
| 156 | MP0005166_decreased_susceptibility_to | 0.49596176 |
| 157 | MP0000689_abnormal_spleen_morphology | 0.49595565 |
| 158 | MP0000639_abnormal_adrenal_gland | 0.49442112 |
| 159 | MP0001533_abnormal_skeleton_physiology | 0.49371618 |
| 160 | MP0003638_abnormal_response/metabolism_ | 0.48963099 |
| 161 | MP0008874_decreased_physiological_sensi | 0.47785101 |
| 162 | MP0005266_abnormal_metabolism | 0.47667595 |
| 163 | MP0003075_altered_response_to | 0.47401985 |
| 164 | MP0000371_diluted_coat_color | 0.47052422 |
| 165 | MP0001984_abnormal_olfaction | 0.46998877 |
| 166 | MP0000249_abnormal_blood_vessel | 0.45313689 |
| 167 | MP0004130_abnormal_muscle_cell | 0.45022227 |
| 168 | MP0003172_abnormal_lysosome_physiology | 0.45019512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.93413687 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.78310452 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.78310452 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 6.78310452 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 6.26919387 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.21845768 |
| 7 | Deep venous thrombosis (HP:0002625) | 6.13417390 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.91042775 |
| 9 | Xanthomatosis (HP:0000991) | 5.50714998 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 5.41459520 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 5.08013742 |
| 12 | Joint hemorrhage (HP:0005261) | 4.96750557 |
| 13 | Complement deficiency (HP:0004431) | 4.63275230 |
| 14 | Loss of speech (HP:0002371) | 4.42713040 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06955234 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.00758644 |
| 17 | Hyperammonemia (HP:0001987) | 3.95125901 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 3.86161259 |
| 19 | Fat malabsorption (HP:0002630) | 3.84437136 |
| 20 | Dysostosis multiplex (HP:0000943) | 3.80360781 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.78993411 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.78111081 |
| 23 | Epidermoid cyst (HP:0200040) | 3.74378798 |
| 24 | Hypokinesia (HP:0002375) | 3.72803925 |
| 25 | Ketosis (HP:0001946) | 3.62622627 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.62286782 |
| 27 | Hyperglycinemia (HP:0002154) | 3.62208299 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.61742071 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.55949425 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.55423172 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.55293962 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.50648714 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.49159107 |
| 34 | Abnormality of complement system (HP:0005339) | 3.44629881 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.36394986 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34866919 |
| 37 | Hyperglycinuria (HP:0003108) | 3.32191928 |
| 38 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.29999928 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.29999928 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.29999928 |
| 41 | Hypoglycemic coma (HP:0001325) | 3.21993932 |
| 42 | Hyperbilirubinemia (HP:0002904) | 3.20801042 |
| 43 | Progressive neurologic deterioration (HP:0002344) | 3.20715939 |
| 44 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.19013779 |
| 45 | Vertebral compression fractures (HP:0002953) | 3.18345536 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 3.17770048 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.17770048 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.17377781 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.13922804 |
| 50 | Steatorrhea (HP:0002570) | 3.10616337 |
| 51 | Nuclear cataract (HP:0100018) | 3.09785786 |
| 52 | Exercise-induced myalgia (HP:0003738) | 3.06105849 |
| 53 | Mucopolysacchariduria (HP:0008155) | 3.04699332 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.04699332 |
| 55 | Myocardial infarction (HP:0001658) | 3.02606241 |
| 56 | Zonular cataract (HP:0010920) | 3.02413657 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 3.00705689 |
| 58 | Hypoplasia of the fovea (HP:0007750) | 2.97031810 |
| 59 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.97031810 |
| 60 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.93305247 |
| 61 | Asymmetric septal hypertrophy (HP:0001670) | 2.83189832 |
| 62 | J-shaped sella turcica (HP:0002680) | 2.82977511 |
| 63 | Ocular albinism (HP:0001107) | 2.74087856 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.70922277 |
| 65 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.70825985 |
| 66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.70411543 |
| 67 | Gingival bleeding (HP:0000225) | 2.64977060 |
| 68 | Abnormality of serum amino acid levels (HP:0003112) | 2.61496050 |
| 69 | Menorrhagia (HP:0000132) | 2.57702119 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 2.55479166 |
| 71 | Delayed CNS myelination (HP:0002188) | 2.51539674 |
| 72 | Ketoacidosis (HP:0001993) | 2.50277353 |
| 73 | Metabolic acidosis (HP:0001942) | 2.49372172 |
| 74 | Axonal loss (HP:0003447) | 2.48691934 |
| 75 | Lethargy (HP:0001254) | 2.46908642 |
| 76 | Glomerulonephritis (HP:0000099) | 2.46831876 |
| 77 | Cerebral edema (HP:0002181) | 2.45395824 |
| 78 | Spontaneous abortion (HP:0005268) | 2.44376793 |
| 79 | Iris hypopigmentation (HP:0007730) | 2.42252125 |
| 80 | Nemaline bodies (HP:0003798) | 2.40884401 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.39688362 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39688362 |
| 83 | Vascular calcification (HP:0004934) | 2.38509568 |
| 84 | Pancreatitis (HP:0001733) | 2.37139368 |
| 85 | Tongue fasciculations (HP:0001308) | 2.36542034 |
| 86 | Diminished movement (HP:0002374) | 2.36356350 |
| 87 | Mutism (HP:0002300) | 2.34351721 |
| 88 | Apathy (HP:0000741) | 2.34237769 |
| 89 | Prolonged neonatal jaundice (HP:0006579) | 2.33210741 |
| 90 | Distal arthrogryposis (HP:0005684) | 2.32748466 |
| 91 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.30993771 |
| 92 | Abnormality of purine metabolism (HP:0004352) | 2.30292958 |
| 93 | Muscle fiber inclusion bodies (HP:0100299) | 2.30145574 |
| 94 | Neurofibrillary tangles (HP:0002185) | 2.27839299 |
| 95 | Mitral stenosis (HP:0001718) | 2.27031401 |
| 96 | Ulnar deviation of the wrist (HP:0003049) | 2.26774849 |
| 97 | Abnormality of the fovea (HP:0000493) | 2.26744505 |
| 98 | Late onset (HP:0003584) | 2.25843792 |
| 99 | Reduced antithrombin III activity (HP:0001976) | 2.24176232 |
| 100 | Vacuolated lymphocytes (HP:0001922) | 2.23448490 |
| 101 | Acanthocytosis (HP:0001927) | 2.22508208 |
| 102 | Skin nodule (HP:0200036) | 2.21285377 |
| 103 | Generalized aminoaciduria (HP:0002909) | 2.20729486 |
| 104 | Opisthotonus (HP:0002179) | 2.17884223 |
| 105 | Trismus (HP:0000211) | 2.15920338 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 2.15832155 |
| 107 | Epistaxis (HP:0000421) | 2.14633300 |
| 108 | Hypochromic microcytic anemia (HP:0004840) | 2.14376784 |
| 109 | Diminished motivation (HP:0000745) | 2.13437476 |
| 110 | Round ear (HP:0100830) | 2.12407380 |
| 111 | Thrombophlebitis (HP:0004418) | 2.12018243 |
| 112 | Bulbar palsy (HP:0001283) | 2.11913496 |
| 113 | Brushfield spots (HP:0001088) | 2.11032190 |
| 114 | Cardiomegaly (HP:0001640) | 2.10583799 |
| 115 | Distal lower limb muscle weakness (HP:0009053) | 2.09180866 |
| 116 | Abnormal gallbladder morphology (HP:0012437) | 2.09078500 |
| 117 | Abnormal gallbladder physiology (HP:0012438) | 2.07487713 |
| 118 | Cholecystitis (HP:0001082) | 2.07487713 |
| 119 | Elevated hepatic transaminases (HP:0002910) | 2.06997776 |
| 120 | Abnormality of the Achilles tendon (HP:0005109) | 2.06915944 |
| 121 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.06225512 |
| 122 | Upper motor neuron abnormality (HP:0002127) | 2.05519886 |
| 123 | Renal cortical cysts (HP:0000803) | 2.04712990 |
| 124 | Cerebral inclusion bodies (HP:0100314) | 2.04592303 |
| 125 | Achilles tendon contracture (HP:0001771) | 2.03781420 |
| 126 | Pulmonary embolism (HP:0002204) | 2.03506167 |
| 127 | Muscle fibrillation (HP:0010546) | 2.02649447 |
| 128 | Neonatal onset (HP:0003623) | 2.02566173 |
| 129 | Cardiovascular calcification (HP:0011915) | 2.01937640 |
| 130 | Vomiting (HP:0002013) | 2.00501510 |
| 131 | Irritability (HP:0000737) | 2.00365573 |
| 132 | Hypoglycemic seizures (HP:0002173) | 2.00326353 |
| 133 | Exercise-induced muscle cramps (HP:0003710) | 1.99975537 |
| 134 | Patchy hypopigmentation of hair (HP:0011365) | 1.99636309 |
| 135 | Myopathic facies (HP:0002058) | 1.98670182 |
| 136 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.98140873 |
| 137 | Sensorimotor neuropathy (HP:0007141) | 1.97493512 |
| 138 | White forelock (HP:0002211) | 1.96136484 |
| 139 | Generalized hypopigmentation (HP:0007513) | 1.95969692 |
| 140 | Cholelithiasis (HP:0001081) | 1.95621562 |
| 141 | Neuronal loss in central nervous system (HP:0002529) | 1.93975533 |
| 142 | Metaphyseal irregularity (HP:0003025) | 1.93317421 |
| 143 | Malnutrition (HP:0004395) | 1.93302631 |
| 144 | Short nail (HP:0001799) | 1.93112662 |
| 145 | Myoglobinuria (HP:0002913) | 1.91974392 |
| 146 | Rhabdomyolysis (HP:0003201) | 1.91206837 |
| 147 | Spastic diplegia (HP:0001264) | 1.91103331 |
| 148 | Increased serum ferritin (HP:0003281) | 1.89925423 |
| 149 | Esophageal varix (HP:0002040) | 1.89294984 |
| 150 | Poikilocytosis (HP:0004447) | 1.88902615 |
| 151 | Progressive muscle weakness (HP:0003323) | 1.88673336 |
| 152 | Purpura (HP:0000979) | 1.88649403 |
| 153 | Hemorrhage of the eye (HP:0011885) | 1.88059445 |
| 154 | Increased connective tissue (HP:0009025) | 1.86731593 |
| 155 | Stridor (HP:0010307) | 1.84806183 |
| 156 | Akinesia (HP:0002304) | 1.84428527 |
| 157 | EMG: myopathic abnormalities (HP:0003458) | 1.83442873 |
| 158 | Joint swelling (HP:0001386) | 1.83023858 |
| 159 | Mesangial abnormality (HP:0001966) | 1.82052316 |
| 160 | Hand muscle atrophy (HP:0009130) | 1.81564752 |
| 161 | Microcytic anemia (HP:0001935) | 1.80969437 |
| 162 | Esophageal neoplasm (HP:0100751) | 1.79808062 |
| 163 | Neoplasm of head and neck (HP:0012288) | 1.79808062 |
| 164 | Alkalosis (HP:0001948) | 1.78529891 |
| 165 | Beaking of vertebral bodies (HP:0004568) | 1.77126977 |
| 166 | Distal upper limb amyotrophy (HP:0007149) | 1.76797900 |
| 167 | Upper limb amyotrophy (HP:0009129) | 1.76797900 |
| 168 | Frequent falls (HP:0002359) | 1.76094056 |
| 169 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.75937284 |
| 170 | Hypertriglyceridemia (HP:0002155) | 1.75812963 |
| 171 | Abnormality of urine glucose concentration (HP:0011016) | 1.74825916 |
| 172 | Glycosuria (HP:0003076) | 1.74825916 |
| 173 | Abnormality of the gallbladder (HP:0005264) | 1.74793997 |
| 174 | Nephritis (HP:0000123) | 1.73232024 |
| 175 | Increased CSF protein (HP:0002922) | 1.72721766 |
| 176 | Enlarged kidneys (HP:0000105) | 1.72623030 |
| 177 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.72351482 |
| 178 | * Amyloidosis (HP:0011034) | 1.71778263 |
| 179 | Disinhibition (HP:0000734) | 1.69919299 |
| 180 | Cervical subluxation (HP:0003308) | 1.69845667 |
| 181 | * Dementia (HP:0000726) | 1.69749227 |
| 182 | Generalized amyotrophy (HP:0003700) | 1.69460806 |
| 183 | Interstitial pulmonary disease (HP:0006530) | 1.68013153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.95931292 |
| 2 | TAOK3 | 3.36260923 |
| 3 | FGFR4 | 3.33924237 |
| 4 | ERN1 | 3.33482356 |
| 5 | LIMK1 | 2.93443831 |
| 6 | PDK2 | 2.88519415 |
| 7 | PHKG1 | 2.68162096 |
| 8 | PHKG2 | 2.68162096 |
| 9 | MAP4K1 | 2.59995633 |
| 10 | TESK1 | 2.56922832 |
| 11 | TYK2 | 2.55656308 |
| 12 | SIK1 | 2.48904123 |
| 13 | IRAK3 | 2.33867575 |
| 14 | MAP3K14 | 2.24151868 |
| 15 | TBK1 | 2.21479920 |
| 16 | TAOK2 | 2.11432453 |
| 17 | IKBKE | 1.97948898 |
| 18 | MST1R | 1.92678952 |
| 19 | TXK | 1.86875938 |
| 20 | EPHA2 | 1.85096270 |
| 21 | INSRR | 1.82938318 |
| 22 | KDR | 1.81944838 |
| 23 | MOS | 1.74400452 |
| 24 | OBSCN | 1.73669366 |
| 25 | DDR2 | 1.72548362 |
| 26 | PAK4 | 1.71266291 |
| 27 | MUSK | 1.67455309 |
| 28 | TESK2 | 1.64873060 |
| 29 | ZAP70 | 1.64473913 |
| 30 | MAP3K12 | 1.63252608 |
| 31 | KIT | 1.62957944 |
| 32 | FLT3 | 1.62799579 |
| 33 | TTN | 1.62345568 |
| 34 | BLK | 1.62178980 |
| 35 | JAK1 | 1.56850260 |
| 36 | NME2 | 1.56275065 |
| 37 | ERBB4 | 1.54423768 |
| 38 | IRAK4 | 1.51153352 |
| 39 | MAPK11 | 1.50021950 |
| 40 | MAP3K9 | 1.46324357 |
| 41 | MAPK15 | 1.44400884 |
| 42 | PIK3CG | 1.38412769 |
| 43 | TGFBR2 | 1.38142597 |
| 44 | MAP2K3 | 1.37905749 |
| 45 | ICK | 1.36431375 |
| 46 | LMTK2 | 1.35313319 |
| 47 | TAOK1 | 1.34900252 |
| 48 | JAK3 | 1.33831267 |
| 49 | NLK | 1.31163028 |
| 50 | NEK9 | 1.30175823 |
| 51 | IKBKB | 1.29236332 |
| 52 | MET | 1.28769646 |
| 53 | JAK2 | 1.26532186 |
| 54 | STK16 | 1.25245489 |
| 55 | NEK1 | 1.22648340 |
| 56 | GRK6 | 1.17527825 |
| 57 | ABL2 | 1.16436805 |
| 58 | TEC | 1.16101152 |
| 59 | EIF2AK1 | 1.12315239 |
| 60 | SYK | 1.11336269 |
| 61 | BTK | 1.11150069 |
| 62 | EPHA3 | 1.09396642 |
| 63 | CAMK1D | 1.07841670 |
| 64 | MAP2K4 | 1.03486242 |
| 65 | MAP2K6 | 1.02883939 |
| 66 | CSK | 1.02487769 |
| 67 | MATK | 1.01461863 |
| 68 | CSF1R | 1.01112369 |
| 69 | IRAK1 | 0.99410804 |
| 70 | PTK2 | 0.99111710 |
| 71 | CDC42BPA | 0.96832940 |
| 72 | MAPK4 | 0.96825606 |
| 73 | TIE1 | 0.94164256 |
| 74 | PIM2 | 0.92921521 |
| 75 | TRIM28 | 0.89817517 |
| 76 | BRAF | 0.89700829 |
| 77 | PKN2 | 0.89559000 |
| 78 | MAP4K2 | 0.89470340 |
| 79 | TRIB3 | 0.85909509 |
| 80 | LYN | 0.84556059 |
| 81 | MAP3K11 | 0.83831759 |
| 82 | PINK1 | 0.83052381 |
| 83 | AKT2 | 0.82486532 |
| 84 | DAPK2 | 0.81275139 |
| 85 | PRKCI | 0.80598401 |
| 86 | PRKAA2 | 0.79654972 |
| 87 | FRK | 0.79474367 |
| 88 | MAP3K13 | 0.78698415 |
| 89 | FER | 0.77750715 |
| 90 | TNK2 | 0.76222347 |
| 91 | GRK1 | 0.75549725 |
| 92 | PRKCQ | 0.75057036 |
| 93 | * CSNK1G3 | 0.74676051 |
| 94 | MST4 | 0.74676005 |
| 95 | LCK | 0.74019124 |
| 96 | * CSNK1G1 | 0.72422253 |
| 97 | MAP3K5 | 0.71674048 |
| 98 | TSSK6 | 0.68038644 |
| 99 | ITK | 0.67729382 |
| 100 | NME1 | 0.67317072 |
| 101 | SRPK1 | 0.66990016 |
| 102 | EPHB1 | 0.66782334 |
| 103 | PIM1 | 0.65163252 |
| 104 | CAMK2D | 0.64755842 |
| 105 | BUB1 | 0.64582134 |
| 106 | SCYL2 | 0.64205898 |
| 107 | DAPK3 | 0.63792825 |
| 108 | MAPKAPK3 | 0.63677449 |
| 109 | DAPK1 | 0.63567583 |
| 110 | MAPK12 | 0.62331470 |
| 111 | TTK | 0.61980279 |
| 112 | CHUK | 0.61250665 |
| 113 | PBK | 0.59486431 |
| 114 | BMPR2 | 0.58898668 |
| 115 | IRAK2 | 0.57664259 |
| 116 | HCK | 0.56389281 |
| 117 | PTK6 | 0.56232785 |
| 118 | CASK | 0.55223228 |
| 119 | EEF2K | 0.54937588 |
| 120 | MAP3K6 | 0.54774824 |
| 121 | GRK7 | 0.54678913 |
| 122 | MAP2K2 | 0.54201256 |
| 123 | MAP3K1 | 0.54199770 |
| 124 | EPHA4 | 0.54093917 |
| 125 | MAP3K3 | 0.52889247 |
| 126 | MAPKAPK5 | 0.52573414 |
| 127 | FGFR3 | 0.52360783 |
| 128 | TRPM7 | 0.51995678 |
| 129 | CAMK1G | 0.51901995 |
| 130 | STK38 | 0.51876649 |
| 131 | CAMK2G | 0.51201207 |
| 132 | PRKD2 | 0.50089139 |
| 133 | PDPK1 | 0.48987777 |
| 134 | AURKA | 0.48661440 |
| 135 | ARAF | 0.47629029 |
| 136 | EIF2AK3 | 0.45814178 |
| 137 | GSK3A | 0.45766150 |
| 138 | ABL1 | 0.44897958 |
| 139 | PAK1 | 0.44474612 |
| 140 | NEK6 | 0.43076549 |
| 141 | PRKACG | 0.42671961 |
| 142 | PRKD3 | 0.42096343 |
| 143 | MAP3K7 | 0.40606193 |
| 144 | FGR | 0.40578770 |
| 145 | MTOR | 0.40067841 |
| 146 | FES | 0.40041305 |
| 147 | DYRK1B | 0.39491811 |
| 148 | HIPK2 | 0.38390111 |
| 149 | IGF1R | 0.38231297 |
| 150 | RIPK1 | 0.38106129 |
| 151 | MAPK3 | 0.37914145 |
| 152 | PRKG2 | 0.37063496 |
| 153 | ADRBK2 | 0.36905268 |
| 154 | PRKCZ | 0.36782347 |
| 155 | MAP3K8 | 0.36370797 |
| 156 | PRKCD | 0.35279324 |
| 157 | MARK3 | 0.35239116 |
| 158 | CDK9 | 0.34927879 |
| 159 | RPS6KA2 | 0.34809070 |
| 160 | * CSNK1G2 | 0.33835210 |
| 161 | MAP3K10 | 0.33272254 |
| 162 | MAP3K2 | 0.30509866 |
| 163 | MYLK | 0.27312562 |
| 164 | ACVR1B | 0.26508174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.52180341 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38955893 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.87797638 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.86383769 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.82214570 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79595070 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57427593 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.56155915 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55449338 |
| 10 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.44573592 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.39346724 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.32922074 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.27285569 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.25335066 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24723415 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.23267048 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.15472832 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11871075 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.05990719 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.02857948 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02062726 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95443068 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92261940 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87953830 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.87786100 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87653550 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79062688 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77512273 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76450473 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73272202 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72997631 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.72168218 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.66618076 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64334089 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57677321 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.57136982 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51863895 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51402412 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.51018633 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49148610 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.45478891 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42879496 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.40331286 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38176251 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.35821704 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35585097 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.33222605 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 1.32284011 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.32249830 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30853212 |
| 51 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27749227 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.25723589 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.25574997 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20262873 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20150156 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17562833 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.16078875 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10652221 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08565578 |
| 60 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.03721461 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01183796 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98824960 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97563510 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91902738 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91136227 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87482551 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85563231 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84046634 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81221238 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.76676379 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73319884 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71730904 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70665428 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67943085 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66511543 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.64473886 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62713920 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62051219 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58887241 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54516681 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54364119 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51179852 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.50155026 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.49443856 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49411567 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47357317 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43273729 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.41908632 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40270358 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39424086 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.38387330 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37768657 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36554811 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35525068 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34709059 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.34574338 |
| 97 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34500307 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34293892 |
| 99 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34051566 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.33613734 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32577158 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32401399 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31327341 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30601899 |
| 105 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.28975661 |
| 106 | Protein export_Homo sapiens_hsa03060 | 0.28323580 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27794807 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26638162 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25922526 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24478713 |
| 111 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24224257 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23116571 |
| 113 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.22205390 |
| 114 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.21282397 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.18199624 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.16234947 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.14641286 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.13963939 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12635899 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12622886 |
| 121 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.11914555 |
| 122 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.10499244 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.10059455 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.07559790 |
| 125 | Malaria_Homo sapiens_hsa05144 | 0.06862827 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.06436808 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.06199177 |
| 128 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.05970555 |
| 129 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.05686981 |
| 130 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.04441501 |
| 131 | Hepatitis C_Homo sapiens_hsa05160 | 0.04221169 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03405031 |
| 133 | Leishmaniasis_Homo sapiens_hsa05140 | 0.02285711 |
| 134 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.02185445 |
| 135 | Measles_Homo sapiens_hsa05162 | -0.0168423 |
| 136 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0162478 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0144676 |

